Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
This introductory course provides a foundation for providing care to patients experiencing a cancer diagnosis, treatment complications, or trouble coping. You’ll cover a range of basic topics, from cancer biology, treatments, symptom management, and patient and family care.
Learn about the care of patients undergoing treatment for urothelial cancer in an engaging case study format.
Oncology advanced practice providers should have comprehensive knowledge and competency in the area of survivorship care. This module explores the considerations and principles of comprehensive survival care of the patient with cancer.
Larry is an 83-year-old rancher who was diagnosed with pancreatic adenocarcinoma and treated with gemcitabine and nab-paclitaxel. A three-month follow-up scan reveals recurrent disease. Larry’s son tells you he wants to explore clinical trials but is frustrated that several promising trials do not accept patients older than 70 years. He asks you why a person’s chronologic age is a major exclusion factor and their performance status is only considered after they meet the age criteria. He also asks you whether his father’s age influenced the choice between first-line therapy with FOLFIRINOX or gemcitabine and nab-paclitaxel.
This module explores unique professional issues that accompany advanced oncology nursing practice. Explore topics including APRN education, accreditation, licensure, and certification standards, as well as professional roles and state practice acts.
Viral infections such as HIV may increase a person’s risk for developing several malignancies. However, most investigational drug studies exclude HIV-positive patients with cancer and optimal treatment regimens remain unknown.
Serving on a board of directors is an effective way to engage and implement the change that you’d like to see in your practice. Use your experience to shape the future for oncology nurses and patient care either through ONS or at any number of healthcare
For the four most common cancer sites (breast, prostate, colorectal, and lung cancer), the median age of patients in clinical trials is an average of 6.5 years younger than the median age of patients diagnosed with that cancer. And the age disparity is worsening, researchers reported in JAMA Oncology.